ghk-cu + epithalon Fountain of Youth Blend GHK-Cu + Epithalon Anti-Aging Blend
Description
EBioMedicine 2017, doi:10.1016/j.ebiom.2017.04.013
Absence of expected improvement by mid-protocol (4-6 weeks) warrants reassessment
The 28% nausea rate is dramatically lower than Wegovys 44%, and the discontinuation rate of 11.2% is reasonable given the unprecedented efficacy
The clinical titration starts at 0.25 mg weekly and increases every four weeks up to a maintenance dose of 2.4 mg weekly, though some research protocols extend up to 4.5 mg
